Pain in Parkinson's disease

Current Treatment Options in Neurology

Volumn 6, Issue 3, 2004, Pages 191-200

  Sage, Jacob I ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMANTADINE; ANALGESIC AGENT; APOMORPHINE; ASCORBIC ACID; BACLOFEN; CAFFEINE; CATECHOL METHYLTRANSFERASE INHIBITOR; CLOZAPINE; DOMPERIDONE; DOPA; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; ENTACAPONE; GABAPENTIN; GLYCINE; LEVODOPA; LITHIUM; MINERAL OIL; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE; SELEGILINE; SELENIUM; SEROTONIN UPTAKE INHIBITOR; TOLCAPONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

ABDOMINAL PAIN; AGRANULOCYTOSIS; AKATHISIA; BRAIN DEPTH STIMULATION; CHOREA; CONTROLLED RELEASE FORMULATION; DIET THERAPY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DIZZINESS; DOPAMINERGIC ACTIVITY; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG COST; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; DYSKINESIA; DYSTONIA; FOOD DRUG INTERACTION; FREQUENCY ANALYSIS; GENITAL PAIN; GLOBUS PALLIDUS; HALLUCINATION; HUMAN; IMMOBILIZATION; INJECTION SITE; LIFESTYLE; LIVER DYSFUNCTION; LIVER TOXICITY; NAUSEA; NIGHTMARE; PAIN; PARESTHESIA; PARKINSON DISEASE; RADICULOPATHY; RESTLESS LEGS SYNDROME; REVIEW; SKIN IRRITATION; SOMNOLENCE; SUBTHALAMIC NUCLEUS; SURGICAL TECHNIQUE; TREMOR; TRIGEMINUS NEURALGIA;

EID: 3142743144     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-004-0011-x     Document Type: Review

References (27)

1. Charcot JM: Oeuvres Completes, vol 1. Paris: Bureaux du Progres Medical; 1892.
2. Goetz CG, Tanner CM, Levy M,et al.: Pain in Parkinson's disease. Mov Disord 1986, 1:45-49.
3. Ford B. Pain in Parkinson's disease. Clin Neurosci 1998, 5:63-72.
4. Hillen ME, Sage JI: Nonmotor fluctuations in patients with Parkinson's disease. Neurology 1996, 47:1180-1183.
5. McHale DM, Sage JI, Sonsalla PK, Vitagliano D: Complex dystonia of Parkinson's disease: clinical features and relation to plasma levodopa profile. Clin Neuropharmacol 1990, 13:164-170.
6. Quinn NP, Lang AE, Koller WC, Marsden CD: Painful Parkinson's disease. Lancet 1986, 1:1366-1369.
7. Waseem S, Gwinn-Hardy K: Pain in Parkinson's disease. Postgrad Med 2001, 110:33-40.
8. Sage JI, Kortis HI, Sommer W: evidence for the role of spinal cord systems in Parkinson's disease-associated pain. Clin Neuropharmacol 1990, 13:171-174.
9. Comella CA, Goetz CG: Akathisia in Parkinson's disease. Mov disord 1994, 9:545-549.
10. Lang AE, Johnson K: Akathisia in idiopathic Parkinson's disease. Neurology 1987, 37:477-481.
11. Ford B, Louis ED, Greene P, Fahn S: Oral and genital pain syndromes in Parkinson's disease. Mov Disord 1996, 11:421-426.
12. Snider SR, Fahn S, Isgreen WP, Cote LJ: Primary sensory symptoms in parkinsonism. Neurology 1976, 26:423-429.
13. Schott GD: Pain in Parkinson's disease. pain 1985, 22:407-411.
14. Cleeves L, Findley L: Frozen shoulder and other shoulder distrubances in Parkinson's disease. J Neurol Neurosurg Psychiatry 1989, 52:813-814.
15. Linazasoro G, marti Masso JF, Suarez A: Nocturnal akathisia in Parkinson's disease: treatment with clozapine. Mov Disord 1993, 8:171-174.
16. Juncos JL: Clozapine: treatment of parkinsonian pain syndromes. Mov Disord 1996, 11:603-604.
17. Quinn NP, Marsden CD: Lithium for painful dystonia in Parkinson's disease. Lancet 1986, 1:1366-1369.
18. Lees AJ, shaw KM, Stern GM: Baclofen in Parkinson's disease. J Neurol Neurosurg Psychiatry 1984, 41:707-708.
19. Chana P, Marinis A, Barrientos N. Gabapentin and motor fluctuations in Parkinson's disease. Mov Disord 1997, 12:608.
20. Syed N, Murphy J, Zimmerman T, et al.: Ten years' experience with enternal levodopa infusions for motor fluctuations in Parkinson'sdisease. Mov Disord 1998, 13:336-338.
21. Loher TJ, Burgunder JM, Weber S, et al.: Effect of chronic pallidal deep brain stimulation on off period dystonia and sensorysymptomsin advanced Parkinson's disease. J Neurol Neurosurg Psychiatry 2002, 73:395-399.
22. Mark MH, Sage JI: Levodopa-associated hemifacial dystonia. Mov Disord 1991, 6:383.
23. Snider SR, Fahn S, Cote LJ, Isgreen WP: Pain, paresthesia and parkinsonism. N Engl J Med 1975, 293:200.
24. Starkstein SE, Preziosi TJ, Robinson RG: sleep disorders, pain, and depression in Parkinson's disease. Eur Neurol 1991, 31:352-355.
25. Goetz CG, Wilson RS, Tanner CM, Garron DC: Relationships among pain, depression and sleep alterations in Parkinson's disease. In Advances in Neurology. edited by Yahr MD, Bergmann KJ. Raven Press, New York; 1986:345-347.
26. Pacchetti C, Albani G, Martignoni E, et al.: "Off" painful dystonia in Parkinson's disease treated with botulinum toxin. Mov Disord 1995, 10:333-336.
27. Factor SA, Molho ES: Emergency department presentations of patients with Parkinson's disease. Am J Emerg Med 2000, 18:209-215.